SANTA MONICA, CA--(Marketwire - January 6, 2009) - Cord Blood America, Inc. (OTCBB: CBAI), announced today that the Company will begin to engage its clients, prospective clients, shareholders and prospective investors via social media. Cord Blood America is currently on Twitter, Facebook and soon to be available on FriendFeed. Cord Blood America will use social media platforms to develop relationships and build networks as well as answer questions regarding their business. Cord Blood America's address on Twitter is http://www.twitter.com/cbai. Cord Blood America is an umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally.

"It's time to start the conversation," said Cord Blood America's founder and CEO Matthew Schissler. Cord Blood America will have a running dialog via these social media outlets, to translate the daily news about stem cells to such a degree that the global population can become informed and participate. "The word 'stem cells' invokes many thoughts, yet we have found that the vast majority of the population still does not know what they are, where they come from or how they dramatically impact almost all aspects of life as we know it. To most, 'stem cells' is a scientific term that has no direct impact on the individual. It's our belief that most people want to understand in a practical fashion, how stem cells affect their family directly. This is the purpose of the social media, to deliver in a user friendly fashion, practical information about stem cells. We intend to look at the issue from multiple angles, including medically from the eyes of the patients and health care practitioners, fundamentally from the scientists, economically from the investor and business perspective, and socially from a public policy perspective."

Schissler continued, "Social media is growing explosively and this trend, according to all authorities is going to continue. We believe that building a network of clients and investors in two-way communication via social media will establish ourselves and our business as market leaders of the future. We invite you to join us in the conversation at the outlets previously mentioned. Additionally we have set up a social media newsroom at Intelligendo.com; we will leverage this newsroom and Intelligendo to further our relationship and network building efforts."

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/. To see our social media news room go to http://www.intelligendo.com.